Heterogeneous methylation of DAPK1 promoter has been shown previously in patients with chronic lymphocytic leukemia [30] or diffuse large B-cell lymphoma [31]. The gene discussed is DAPK1; the disease is B-cell chronic lymphocytic leukemia.